CN Patent

CN105503717A — 一种苹果酸卡博替尼化合物及其药物组合物

Assigned to Jiangsu Aosaikang Pharmaceutical Co Ltd · Expires 2016-04-20 · 10y expired

What this patent protects

本发明提供了一种新晶体形式的苹果酸卡博替尼化合物及其制备方法。本发明提供的新晶体形式的苹果酸卡博替尼化合物在高温(40℃)、高湿、光照条件下，具有良好的稳定性，最高单杂、总杂的含量无明显变化。

USPTO Abstract

本发明提供了一种新晶体形式的苹果酸卡博替尼化合物及其制备方法。本发明提供的新晶体形式的苹果酸卡博替尼化合物在高温(40℃)、高湿、光照条件下，具有良好的稳定性，最高单杂、总杂的含量无明显变化。

Drugs covered by this patent

Patent Metadata

Patent number
CN105503717A
Jurisdiction
CN
Classification
—
Expires
2016-04-20
Drug substance claim
No
Drug product claim
No
Assignee
Jiangsu Aosaikang Pharmaceutical Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.